NJ CSIT Catalyst R&D Pilot Seed Grant Program

The NJ CSIT Catalyst R&D Pilot Seed Grant Program is the broader New Jersey Commission on Science, Innovation and Technology seed track for early-stage innovation companies. It supports the shift from research toward commercially viable products and covers most sectors, with therapeutic drug discovery specifically excluded. The program's current round closed after Round 3, and CSIT is between cycles while it prepares the next announcement. Awards go up to $75,000 and the cycle pattern is annual. Eligible applicants are for-profit companies registered in the United States and operating in New Jersey, with revenue below $5 million and one application allowed per entity per round. Companies already receiving two or more CSIT Seed or Demonstration Grants are not eligible. The program also uses a staged payment structure, with 80% released when the grant agreement is executed and the remaining 20% after the final report. This is a good fit for founders who need a modest, non-dilutive step to turn technical work into a product, but who do not sit inside therapeutic drug discovery. The strongest proposals are tightly scoped, practical, and ready to show how a one-year project can produce a commercial milestone rather than just more research.

No upcoming rounds verified. Cadence: Annual.